175 related articles for article (PubMed ID: 20432626)
21. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
22. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
23. The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.
Sezer AD; Akbuğa J
Pharm Dev Technol; 2012; 17(1):118-24. PubMed ID: 20977313
[TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
25. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode.
Xie J; Wang CH
Biotechnol Bioeng; 2007 Aug; 97(5):1278-90. PubMed ID: 17216662
[TBL] [Abstract][Full Text] [Related]
26. Fluorescein isothiocyanate labelled bovine serum albumin (FITC-BSA) as a model protein drug: opportunities and drawbacks.
Wischke C; Borchert HH
Pharmazie; 2006 Sep; 61(9):770-4. PubMed ID: 17020153
[TBL] [Abstract][Full Text] [Related]
27. Mannosylated niosomes as carrier adjuvant system for topical immunization.
Jain S; Vyas SP
J Pharm Pharmacol; 2005 Sep; 57(9):1177-84. PubMed ID: 16105238
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting the particle size and in vitro release of bovine serum albumin from polyethylene glycol microparticles.
Thummala AS; Leach JK; O'Rear EA
Biomed Sci Instrum; 2003; 39():318-23. PubMed ID: 12724913
[TBL] [Abstract][Full Text] [Related]
29. Systemic immune response of young chickens orally immunized with bovine serum albumin.
Mayo SL; Persdotter-Hedlund G; Tufvesson M; Hau J
In Vivo; 2003; 17(3):261-8. PubMed ID: 12929578
[TBL] [Abstract][Full Text] [Related]
30. Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.
Sajeesh S; Sharma CP
J Biomater Sci Polym Ed; 2007; 18(9):1125-39. PubMed ID: 17931503
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
Bhavsar MD; Amiji MM
J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
[TBL] [Abstract][Full Text] [Related]
32. Enhanced immune response induced by BSA loaded in hydroxyethylstarch microparticles.
Balasse E; Odot J; Gatouillat G; Andry MC; Madoulet C
Int J Pharm; 2008 Apr; 353(1-2):131-8. PubMed ID: 18162346
[TBL] [Abstract][Full Text] [Related]
33. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
34. Using procedure of emulsification-lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS).
Wang N; Wang T; Zhang M; Chen R; Deng Y
Int J Pharm; 2014 Jul; 468(1-2):39-49. PubMed ID: 24704308
[TBL] [Abstract][Full Text] [Related]
35. Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats.
Yoshikawa Y; Komuta Y; Nishihara T; Itoh Y; Yoshikawa H; Takada K
J Drug Target; 1999; 6(6):449-61. PubMed ID: 10937290
[TBL] [Abstract][Full Text] [Related]
36. Non-Conjugated Chitosan-Based Nanoparticles to Proteic Antigens Elicit Similar Humoral Immune Responses to Those Obtained with Alum.
Izaguirre-Hernández IY; Mellado-Sánchez G; Mondragón-Vásquez K; Thomas-Dupont P; Sánchez-Vargas LA; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Vivanco-Cid H
J Nanosci Nanotechnol; 2017 Jan; 17(1):846-52. PubMed ID: 29634187
[TBL] [Abstract][Full Text] [Related]
37. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
38. Gel core liposomes: an advanced carrier for improved vaccine delivery.
Tiwari S; Goyal AK; Khatri K; Mishra N; Vyas SP
J Microencapsul; 2009 Feb; 26(1):75-82. PubMed ID: 18608797
[TBL] [Abstract][Full Text] [Related]
39. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy.
Zhao YZ; Li X; Lu CT; Xu YY; Lv HF; Dai DD; Zhang L; Sun CZ; Yang W; Li XK; Zhao YP; Fu HX; Cai L; Lin M; Chen LJ; Zhang M
Acta Diabetol; 2012 Aug; 49(4):315-25. PubMed ID: 22124766
[TBL] [Abstract][Full Text] [Related]
40. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Ofokansi K; Winter G; Fricker G; Coester C
Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
